Research Project · Health
ADDF Diagnostics Accelerator Funding for FTD Biomarker Development
The Association for Frontotemporal Degenerationwww.theaftd.org (opens in a new tab)Catalog updated
- Amount
- $5,000,000
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- Not listed
About this program
The Association for Frontotemporal Degeneration (AFTD) partners with the Alzheimer’s Drug Discovery Foundation (ADDF) Diagnostics Accelerator to fund development of biomarkers for frontotemporal degeneration (FTD). The initiative has provided nearly $5 million through combined AFTD and ADDF support for promising diagnostic research with potential to advance FTD diagnosis and treatment. Funding is intended for research teams developing and validating innovative FTD biomarkers, although specific applicant eligibility and application requirements are not provided in the available information.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 4 similar programs in full.
Ask for a demo of this program The form opens already filled in.